Statins are the most commonly prescribed drug class in the country, yet many of the roughly 93 million people taking them have never heard about a nutrient their medication depletes — one that their own heart and muscles depend on. (Based on the insights of Dr. Eric Berg)
Key Takeaways
- Statins block the same pathway used to produce CoQ10, a compound needed for mitochondrial energy in heart and muscle tissue — a real, well-established mechanism.
- Statins do not currently carry an FDA black box warning; the FDA has specifically declined petitions for one regarding muscle-related risks, though real safety updates (cognitive effects, blood sugar increases) do exist on current labels.
- Evidence for CoQ10 reducing statin-related muscle symptoms is genuinely mixed across clinical trials, not definitively established either way.
- The commonly cited “25-35% reduction in heart attacks” from statins is typically a relative risk figure — the absolute, individual-level benefit is more modest for primary prevention, though meaningfully larger for people who’ve already had a cardiac event.
- Refined carbohydrates, insulin resistance, and bile/gallbladder function are underdiscussed contributors to elevated cholesterol, beyond diet quality alone.
The CoQ10 Connection
Statins work by blocking an enzyme in the cholesterol production pathway. That same pathway is also involved in producing coenzyme Q10 (CoQ10), a compound your mitochondria need to generate energy — particularly in the heart and skeletal muscles. This is a real, well-established pharmacological mechanism, not a fringe claim. Interestingly, a pharmaceutical patent was filed decades ago covering a statin formulated together with CoQ10, though it was never brought to market in that combined form.
Why the Body Makes Cholesterol in the First Place
Cholesterol isn’t simply a health hazard to be minimized at all costs — the body manufactures the majority of its own cholesterol supply because it’s genuinely needed. It’s a structural component of every cell membrane, a precursor for hormones including testosterone, estrogen, and cortisol, a building block for bile, and a precursor for vitamin D production. This doesn’t mean cholesterol levels never matter — it’s context for why the body treats it as an essential molecule rather than pure waste.
Statin Side Effects Worth Knowing
Documented statin side effects include muscle pain, weakness, fatigue, exercise intolerance, and an increased risk of tendon rupture, particularly during exercise. It’s worth being precise about the regulatory picture here: statins do not currently carry an FDA “black box” (boxed) warning, which is the agency’s most serious warning category — the FDA has specifically declined petitions requesting one for muscle-related risks. That said, statin labels do include real, significant safety updates from 2012, including warnings about cognitive effects like memory loss and confusion, and an increased risk of elevated blood sugar and new-onset type 2 diabetes. These are genuine, FDA-acknowledged risks, even without a formal boxed warning attached to them.
Does CoQ10 Actually Help With Statin Side Effects?
This is an area of real, ongoing research, and it’s worth being upfront that the evidence is mixed rather than uniformly conclusive. Several randomized trials and meta-analyses have examined CoQ10 supplementation for statin-associated muscle symptoms, with some showing modest benefit and others finding no significant effect — a pattern often attributed to differences in the dose and form of CoQ10 used across studies. Major cardiology organizations don’t currently issue a formal recommendation for routine CoQ10 supplementation alongside statins, largely reflecting this inconsistency in the evidence rather than a settled dismissal of the idea. If you’re currently taking a statin and experiencing muscle-related symptoms, this is a reasonable, low-risk supplement to discuss with your doctor — ubiquinol, a more readily absorbed form of CoQ10, at doses commonly discussed in the 200-400 mg range, is a starting point some people explore, though individual response and appropriate dosing should be worked out with your doctor.
A Note on Guideline Development
There has been legitimate, published concern in medical literature and journalism about financial relationships between pharmaceutical companies and members of panels that develop cholesterol treatment guidelines. This is a real, documented area of scrutiny in evidence-based medicine broadly, worth being aware of as general context — though the exact scope of these relationships varies by guideline and panel, and isn’t something to overstate into a blanket dismissal of the guidelines themselves.
Understanding Relative Risk vs. Absolute Risk
This is a genuinely important, well-established concept in evidence-based medicine, not a fringe critique. When you hear that statins reduce heart attack risk by “25-35%,” that figure is typically a relative risk reduction — comparing the rate of events in the treatment group to the rate in the placebo group. This is different from absolute risk reduction, which describes how many people out of a group actually avoid a heart attack because of the medication. For primary prevention specifically (people without existing heart disease), published research on the number needed to treat (NNT) — a measure of how many people need to take a medication for a set period for one person to benefit — has found that a substantial majority of people taking a statin for primary prevention over about 5 years see no direct cardiovascular event prevented, even though the medication is genuinely working as intended for the population overall. This doesn’t mean statins don’t work — it means the individual-level benefit for primary prevention is real but modest, while the picture is different for secondary prevention (people who’ve already had a heart attack or have established heart disease), where the absolute benefit is meaningfully larger. This is a nuance worth understanding and discussing with your doctor, not a reason to stop a prescribed medication on your own.
Why Is Your Cholesterol High in the First Place?
Common explanations include diet, diabetes, alcohol use, and hypothyroidism — but refined carbohydrates and sugar are a frequently underdiscussed contributor, since excess carbohydrate intake can directly increase the liver’s cholesterol production. Bile, made in the liver and stored in the gallbladder, plays a role in eliminating excess cholesterol from the body — so gallbladder problems, gallbladder removal, or inadequate bile production can also contribute to elevated cholesterol readings. A fasting insulin test (ideally below 5) is a reasonable additional test to ask your doctor about, since many people with elevated cholesterol also have notably high fasting insulin, reflecting underlying insulin resistance as a contributing factor.
Practical Takeaways
If you’re on a statin and experiencing muscle weakness, pain, fatigue, or exercise intolerance, discuss CoQ10 (specifically ubiquinol) with your doctor. If you’re managing elevated blood sugar or type 2 diabetes alongside statin use, addressing the underlying insulin resistance through diet and activity is a legitimate, complementary focus. Magnesium (commonly discussed around 400 mg of magnesium glycinate) is also a supporting cofactor for mitochondrial energy production, worth discussing alongside CoQ10.
Frequently Asked Questions
Do statins have a black box warning?
No — this is a common misconception. The FDA has specifically declined petitions for a black box warning on statins regarding muscle injury risk. Statins do carry other real, significant label warnings, including for cognitive effects and blood sugar increases, added in 2012.
Does CoQ10 definitely fix statin muscle pain?
The evidence is genuinely mixed — some trials show modest benefit, others show none, often depending on the dose and form of CoQ10 used. It’s a reasonable, low-risk option to discuss with your doctor, not a guaranteed fix.
What’s the difference between relative and absolute risk reduction for statins?
Relative risk reduction (like “25-35%”) compares event rates between treatment and placebo groups, while absolute risk reduction reflects how many individual people actually avoid an event. For primary prevention, the absolute individual benefit is more modest than the relative figure suggests, though secondary prevention (after a cardiac event) shows a meaningfully larger absolute benefit.
Should I stop taking my statin based on this information?
No — never stop or adjust a prescribed statin without consulting your doctor. This information is meant to support a more informed conversation with your doctor, not to replace their guidance.
Quick Start Checklist
- ☐ If on a statin, discuss CoQ10 (ubiquinol) with your doctor, especially if experiencing muscle symptoms
- ☐ Ask your doctor about a fasting insulin test alongside your lipid panel
- ☐ Reduce refined carbohydrates and added sugar if cholesterol is elevated
- ☐ Ask your doctor whether your cholesterol reading reflects primary or secondary prevention context
- ☐ Discuss magnesium as a supporting cofactor if considering CoQ10
- ☐ Never stop or adjust your statin without your doctor’s guidance
Disclaimer: This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Statins do not currently carry an FDA black box warning; this article corrects that specific claim while presenting the real, documented side effects and safety updates that do exist. The evidence for CoQ10 reducing statin side effects is mixed, not definitively established. Never stop or adjust a statin or any prescribed medication without consulting your doctor.